---
title: "Reviews — urolithin a - Flapen"
canonical_url: "https://flapen.com/research/us/health-household/urolithin-a/reviews"
last_updated: "2026-07-21T06:21:56.440Z"
locale: en
meta:
  description: "urolithin a clears our launch bar: a $3.0M/yr market growing +30.4% this quarter with returns at 0.0%. Data updated Jul 2026."
  "og:description": "urolithin a clears our launch bar: a $3.0M/yr market growing +30.4% this quarter with returns at 0.0%. Data updated Jul 2026."
  "og:title": "Reviews — urolithin a - Flapen"
---

# **urolithin a**

**Launch it**

A $3.0M/yr market growing +30.4% this quarter with returns at 0.0% — clears our launch bar.

Market size 96Growth 56Conversion 71Competition 45Returns 100Price range 94Avg price 92Brand share 56Review moat 93Quality gap 60

**Returns**

**Incredible****0.0%**

return rate — above 6% kills the launch gate

**Market size**

**Incredible****$3.0M**

$3.0M/yr · 865K searches

**Price range**

**Great****$18.71–$100.54**

cheapest to priciest tracked listing — scored on the share inside $15–$100

**Review moat**

**Great****145.58**

avg incumbent reviews — the moat a new listing must climb

**Avg price**

**Great****$53.97**

avg listing price — sweet spot $15–$100

**Conversion**

**Good****6.5%**

search→purchase rate — share of searches ending in a sale

**Quality gap**

**Good****4.4★**

avg incumbent rating — lower means beatable quality

**Growth**

**Good****+30.4%**

90-day search growth — must beat 0% to launch

**Brand share**

**Good****71%**

top-5 brand share — brands hold most of the demand

**Competition**

**Okay****58%**

top-5 click share — leaders hold, buyers still browse